Baudax Bio (NASDAQ:BXRX) reported quarterly losses of $(2.47) per share. This is a 64.71 percent increase over losses of $(7.00) per share from the same period last year.
Truist Securities Initiates Coverage On Signify Health with Hold Rating, Announces Price Target of $30.5
Truist Securities analyst Jailendra Singh initiates coverage on Signify Health (NYSE:SGFY) with a Hold rating and announces Price Target of $30.5.